P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL

P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL

Bibliographic Details
Main Authors:	Jesse Tettero, Raffaele Palmieri, Lok Lam Ngai, Costa Bachas, Valentina Arena, Dimitri Breems, Thomas Fischer, Bjorn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus Manz, Luca Maurillo, Thomas Pabst, Jakob Passweg, Alfonso Piciocchi, Kimmo Porkka, Bob Löwenberg, Adriano Venditti, Gert Ossenkoppele, Francesco Buccisano, Jacqueline Cloos
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968636.18625.e3

Similar Items

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
by: Jesse M. Tettero, et al.
Published: (2023-04-01)

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG
by: Roland B. Walter, et al.
Published: (2015-10-01)

Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
by: Niek G. van der Maas, et al.
Published: (2024-03-01)

P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
by: Lok Lam Ngai, et al.
Published: (2023-08-01)

Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI
by: Megan Othus, et al.
Published: (2016-07-01)

Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Leukaemia (AML) in First CR: A survey from HOVON-SAKK and the acute leukaemia working party of the EBMT
by: Craddock, C, et al.
Published: (2016)

P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
by: Sjoerd Hermans, et al.
Published: (2023-08-01)

P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML
by: Jesse Tettero, et al.
Published: (2023-08-01)

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
by: Jesse M. Tettero, et al.
Published: (2023-12-01)

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
by: Marijke Linschoten, et al.
Published: (2025-01-01)

Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
by: Michael Mark, et al.
Published: (2024-09-01)

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum
by: Dimitri A. Breems, et al.
Published: (2011-04-01)

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)
by: Reinhard Zenhäusern, et al.
Published: (2008-09-01)

SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients
by: Marcus Vetter, et al.
Published: (2023-01-01)

Rpg 432 - Rekabentuk Bandar
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (1995)

Ebüssuûd Efendi ve Şânizâde’nin Sakk Kayıtları Işığında İslam ve Osmanlı Hukukunda İcâre (Kira)
by: İbrahim Ülker
Published: (2023-12-01)

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B-ALL IN ADULTS. A PHASE II HOVON TRIAL
by: A. Rijneveld, et al.
Published: (2022-06-01)

The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14
by: Beatrice Drexler, et al.
Published: (2019-04-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
by: Christoph Driessen, et al.
Published: (2016-03-01)

JAH 432/3 - Rekabentuk Hidraulik
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

S249: SELECTIVE JAK2/IRAK1/ACVR1 INHIBITOR PACRITINIB BEFORE REDUCED-INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: FINAL ANALYSIS OF THE PHASE II HOVON-134 TRIAL
by: Ruben Van Dijck, et al.
Published: (2023-08-01)

Advancements in lung cancer: a comprehensive perspective on diagnosis, staging, therapy and follow-up from the SAKK Working Group on Imaging in Diagnosis and Therapy Monitoring
by: Lisa Jungblut, et al.
Published: (2024-12-01)

Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial
by: Annoek E. C. Broers, et al.
Published: (2024-12-01)

JAH432 - REKABENTUK HIDRAULIK. MAC 2002
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2002)

JAH432 - REKABENTUK HIDRAULIK. MAC 2002
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2002)

EEE432 – ANTENNAS AND PROPAGATION JANUARY 2013
by: PPKEE, Pusat Pengajian Kejuruteraan Elektrik & Elektronik
Published: (2013)

JAH432 - REKABENTUK HIDRAULIK. MAC 2003
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2003)

JAH432 - REKABENTUK HIDRAULIK. MAC 2005
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2005)

RPK432 - REKABENTU BANDAR FEBRUARI 1998
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (1998)

EBS432 - Environmental Chemistry For Engineering Practice
by: PPKBSM, Pusat Pengajian Kejuruteraan Bahan dan Sumber Mineral
Published: (2022)

EBS432 Environmental Chemistry For Engineering Practice
by: PPKBSM, Pusat Pengajian Kejuruteraan Bahan dan Sumber Mineral

Introduction to the Intel: iAPX 432 architecture /
by: 318979 Hunter, Colin B., et al.
Published: (1985)

Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)
by: Benjamin Kasenda, et al.
Published: (2023-04-01)

THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.
by: Raffaele Palmieri, et al.
Published: (2023-08-01)

EEE 432 - ANTENA DAN PERAMBATAN NOV 05
by: PPKEE, Pusat Pengajian Kejuruteraan Elektrik & Elektronik
Published: (2005)

KAE 432 - KAEDAH RADIOANALISIS OCT-NOV 95.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1995)

EEE 432 - ANTENA DAN PERAMBATAN OKT 04
by: PPKEE, Pusat Pengajian Kejuruteraan Elektrik & Elektronik
Published: (2004)

BBT432-3 - TEKNOLOGI FERMENTASI - JUN 1992
by: PPSKJ, Pusat Pengajian Sains Kajihayat (School of Biological Sciences)
Published: (1992)

JAH 432-3 - Rekabentuk Hidraulik Mac 2002
by: Pusat Pengajian Jarak Jauh, PPJJ
Published: (2002)

BTT 432/3 - Teknologi Fermentasi - April 1994
by: PPSKJ, Pusat Pengajian Sains Kajihayat
Published: (1994)